Calibrating Models in Economic Evaluation
- 1 January 2011
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 29 (1) , 35-49
- https://doi.org/10.2165/11584600-000000000-00000
Abstract
In economic evaluation, mathematical models have a central role as a way of integrating all the relevant information about a disease and health interventions, in order to estimate costs and consequences over an extended time horizon. Models are based on scientific knowledge of disease (which is likely to change over time), simplifying assumptions and input parameters with different levels of uncertainty; therefore, it is sensible to explore the consistency of model predictions with observational data. Calibration is a useful tool for estimating uncertain parameters, as well as more accurately defining model uncertainty (particularly with respect to the representation of correlations between parameters). Calibration involves the comparison of model outputs (e.g. disease prevalence rates) with empirical data, leading to the identification of model parameter values that achieve a good fit. This article provides guidance on the theoretical underpinnings of different calibration methods. The calibration process is divided into seven steps and different potential methods at each step are discussed, focusing on the particular features of disease models in economic evaluation. The seven steps are (i) Which parameters should be varied in the calibration process? (ii) Which calibration targets should be used? (iii) What measure of goodness of fit should be used? (iv) What parameter search strategy should be used? (v) What determines acceptable goodness-of-fit parameter sets (convergence criteria)? (vi) What determines the termination of the calibration process (stopping rule)? (vii) How should the model calibration results and economic parameters be integrated? The lack of standards in calibrating disease models in economic evaluation can undermine the credibility of calibration methods. In order to avoid the scepticism regarding calibration, we ought to unify the way we approach the problems and report the methods used, and continue to investigate different methods.Keywords
This publication has 47 references indexed in Scilit:
- Calibrating Models in Economic EvaluationPharmacoEconomics, 2011
- Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programmeSexually Transmitted Infections, 2010
- Calibration of Disease Simulation Model Using an Engineering ApproachValue in Health, 2010
- Calibration Methods Used in Cancer Simulation Models and Suggested Reporting GuidelinesPharmacoEconomics, 2009
- Adopting helical CT screening for lung cancerCancer, 2008
- Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccinationPopulation Health Metrics, 2007
- Option appraisal of population-based colorectal cancer screening programmes in EnglandGut, 2007
- What is the achievable effectiveness of the India AIDS Initiative intervention among female sex workers under target coverage? Model projections from southern IndiaSexually Transmitted Infections, 2006
- Recent Developments in Decision-Analytic Modelling for Economic EvaluationPharmacoEconomics, 2006
- Cost-effectiveness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and ItalyJNCI Journal of the National Cancer Institute, 2005